ArticleNature communications2026
Reprogramming product selectivity and activity in promiscuous terpene synthases via substrate conformation engineering.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Terpenoids are structurally diverse natural products with broad applications, yet their biosynthesis is often constrained by the low catalytic efficiency and poor product selectivity of terpene synthases (TPSs). Simultaneously enhancing product specificity and catalytic performance remains a major challenge in TPS engineering. Here, we elucidate the regio- and stereoselectivity of a fungal germacrene A synthase, which catalyzes the 1,10-cyclization of farnesyl diphosphate to form a central sesquiterpene intermediate. The side-chain volume of a non-catalytic residue (T169) adjacent to the substrate pocket modulates substrate-binding conformations, thereby redirecting the carbocation cascade and reshaping the product profile. Mechanism-guided pocket engineering further yielded terpene synthase variants with altered product specificity. Notably, one variant increased (+)-germacrene A production in Escherichia coli by 24.3-fold, reaching 15.8 g L⁻¹ in a bioreactor-the highest titer reported in this host to the best of our knowledge. These results provide mechanistic insight into substrate-conformation-mediated reprogramming of TPS specificity, highlighting a promising strategy for the development of high-performance terpenoid biocatalysts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.